Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study
Journal of Pharmacy & Pharmaceutical Sciences · 10.04.2025 · 28
DOI: 10.3389/jpps.2025.14295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, online erschienen am 10.04.2025. Verfasst von Yunus Emre Ayhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Prof. Dr. Cemil Taşcıoğlu City Hospital, Department of Clinical Pharmacy, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Intensive Care Units, Anti-Ulcer Agents, Peptic Ulcer, Stress, Psychological. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Objective
This study evaluated the use of stress ulcer prophylaxis (SUP), assessed the costs associated with inappropriate use, and highlighted the impact of clinical pharmacists on improving adherence to the SUP guidelines.
Method
A prospective, non-randomized controlled study was carried out in two intensive care units (ICUs) of a training and research hospital between 1 June 2023 and 1 December 2023. Routine care services were provided for the observation group (OG) patients. In the guideline group (GG) patients, SUP management and routine care were performed according to ASHP guidelines. The physician and clinical pharmacist jointly evaluated the patients to determine the suitability of their SUP indications. Adherence rates to ASHP guidelines and the costs associated with nonadherence were evaluated.
Results
A total of 196 patients were included in the study: 121 in the OG and 75 in the GG. A total of 54.6% of the patients were male, and the reason for hospitalization was mainly surgery (52.6%). SUP use was higher in OG (100%) than in GG (42.6%) (p < 0.001). The indication rate according to the ASHP guidelines was significantly higher in the GG group (100%) than in the OG group (54.5%) (p < 0.001). Dosage form adherence was significantly lower in the OG (0%) than in the GG (100%) (p < 0.001). The costs associated with proton pump inhibitor use for inappropriate indications and incorrect dosage forms were $60 versus $0 (p < 0.001) and $321 versus $0 (p < 0.001) in OG and GG, respectively. Overall, cost savings of $327 were achieved in the GG group.
Conclusion
Inappropriate SUP use is common in the ICUs. Adequate adherence to guidelines and proactive involvement of clinical pharmacists may reduce inappropriate SUP in ICUs and the associated costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Prof. Dr. Cemil Taşcıoğlu City Hospital, Department of Clinical Pharmacy, Istanbul, Türkiye.
- Gaziosmanpaşa Education and Research Hospital, Intensive Care, İstanbul, Türkiye.
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Intensive Care, Istanbul, Türkiye.
- Altınbaş University, School of Pharmacy, Department of Clinical Pharmacy, Istanbul, Türkiye.
Zitieren
APA
Ayhan, Y. E., Eskidemir, G., Koçoğlu Kınal, A. G., & Aksoy, N. (2025). Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study. Journal of Pharmacy & Pharmaceutical Sciences, 28. https://doi.org/10.3389/jpps.2025.14295
Vancouver
Ayhan YE, Eskidemir G, Koçoğlu Kınal AG, Aksoy N. Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study. Journal of Pharmacy & Pharmaceutical Sciences. 2025;28. doi:10.3389/jpps.2025.14295
BibTeX
@article{Ayhan2025,
author = {Ayhan, Yunus Emre and Eskidemir, Güneş and Koçoğlu Kınal, Ayşe Gül and Aksoy, Nilay},
title = {Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2025},
volume = {28},
doi = {10.3389/jpps.2025.14295}
}
EUVIMED